Syschem (India)

Why is Syschem (India) Ltd falling/rising?

As of 18-Aug, Syschem (India) Ltd's stock price is declining, currently at Rs 31.07, reflecting a bearish trend with significant investor disinterest and proximity to its 52-week low. The stock has lost value for two consecutive days and is trading below its moving averages.

As of 18-Aug, Syschem (India) Ltd's stock price is falling, currently at Rs 31.07, which reflects a decrease of Rs 0.48 or 1.52%. The stock has been underperforming, having lost value for the last two consecutive days, with a total decline of 2.14% during this period. Additionally, the stock is trading below its moving averages across various time frames, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, indicating a bearish trend.<BR><BR>Investor participation has also decreased significantly, with delivery volume dropping by 73.68% compared to the 5-day average, suggesting reduced interest from investors. Furthermore, the stock is close to its 52-week low, being only 2% away from the low of Rs 30.45. Overall, these factors contribute to the downward pressure on Syschem (India) Ltd's stock price.

Which are the latest news on Syschem (India)?

Who are in the management team of Syschem (India)?

The management team of Syschem (India) includes Ranjan Jain (Executive Director & Managing Director), Suninder Veer Singh (Executive Director & Wholetime Director), Arshdeep Kaur (Independent Non-Executive Director), Neena Batra (Non-Executive & Non-Independent Director), and Renu Rawat (Independent Non-Executive Director).

The management team of Syschem (India) includes the following members:<BR><BR>1. Ranjan Jain - Executive Director & Managing Director<BR>2. Suninder Veer Singh - Executive Director & Wholetime Director<BR>3. Arshdeep Kaur - Independent Non-Executive Director<BR>4. Neena Batra - Non-Executive & Non-Independent Director<BR>5. Renu Rawat - Independent Non-Executive Director<BR><BR>If you need more information about any specific member or their roles, feel free to ask!

What does Syschem (India) do?

Syschem (India) Ltd manufactures Active Pharmaceutical Ingredients (API) and intermediates in the Pharmaceuticals & Biotechnology sector. As of June 2026, it reported net sales of 109 Cr and a net profit of -2 Cr, with a market cap of INR 156 Cr.

Overview:<BR>Syschem (India) Ltd is engaged in the manufacturing of Active Pharmaceutical Ingredients (API) and intermediates, operating within the Pharmaceuticals & Biotechnology industry and categorized as a Micro Cap company.<BR><BR>History:<BR>The company was incorporated on 31 December 1993 and was formerly known as Anil Pesticides Limited until it changed its name to Syschem (India) Limited on February 17, 2003. The latest quarterly results reported net sales and profit for June 2026.<BR><BR>Financial Snapshot:<BR>- Net Sales: 109 Cr (Quarterly Results - Jun 2026)<BR>- Net Profit: -2 Cr (Quarterly Results - Jun 2026)<BR>- Market Cap: INR 156 Cr (Micro Cap)<BR><BR>Key Metrics:<BR>- P/E: 25.00<BR>- Industry P/E: 44<BR>- Dividend Yield: 0.00%<BR>- Debt Equity: -0.05<BR>- Return on Equity: 6.47%<BR>- Price to Book: 1.61<BR><BR>Contact Details:<BR>- Address: Tehsil Kalka, Bargodam Village Panchkula Haryana : 133302<BR>- Tel: 91-172-3077777<BR>- Email: info@syschem.in<BR>- Website: http://www.syschem.in

Who are the peers of the Syschem (India)?

Syschem (India) peers include Achyut Healthcar, Natural Capsules, Panch.Organics, Parnax Lab, Auro Labs, Smruthi Organic, Bal Pharma, and Quest Laborato. Syschem shows good growth and capital structure but has a 1-year return of -33.66%, lower than its peers.

Peers: The peers of Syschem (India) are Achyut Healthcar, Natural Capsules, Panch.Organics, Parnax Lab, Auro Labs., Smruthi Organic, Bal Pharma, and Quest Laborato.<BR><BR>Quality Snapshot: Below Average management risk is observed at Achyut Healthcar, Natural Capsules, Syschem (India), and the rest. Average management risk is found at Panch.Organics, Auro Labs., Smruthi Organic, Bal Pharma, and the rest. Good growth is noted at Syschem (India), Parnax Lab, while Average growth is seen at Achyut Healthcar, and the rest, with Below Average growth at Natural Capsules, Panch.Organics, Auro Labs., Smruthi Organic, Bal Pharma, and the rest. Good capital structure is present at Syschem (India), while Excellent capital structure is noted at Panch.Organics, Parnax Lab, and the rest, with Below Average capital structure at Natural Capsules, Auro Labs., Bal Pharma, and the rest.<BR><BR>Return Snapshot: The peer with the highest 1-year return is Guj. Inject(Ker) at 469.95%, while Natural Capsules has the lowest at -28.67%. Syschem (India) has a 1-year return of -33.66%, which is lower than both of these peers. Additionally, Natural Capsules, Syschem (India), Auro Labs., and Bal Pharma have negative six-month returns.

How big is Syschem (India)?

As of 14th August, Syschem (India) Ltd has a market capitalization of 155.00 Cr, with recent net sales of 573.66 Cr and a net profit of 6.14 Cr. The balance sheet for March 2025 shows shareholder's funds of 91.29 Cr and total assets of 216.87 Cr.

As of 14th August, Syschem (India) Ltd has a market capitalization of 155.00 Cr, categorizing it as a Micro Cap company.<BR><BR>In the latest four quarters, Syschem (India) reported Net Sales of 573.66 Cr and a Net Profit of 6.14 Cr.<BR><BR>The latest annual period for the balance sheet is March 2025, showing Shareholder's Funds of 91.29 Cr and Total Assets of 216.87 Cr.

Are Syschem (India) Ltd latest results good or bad?

Syschem (India) Ltd's latest Q1 FY27 results are concerning, showing a net loss of ₹1.67 crores and a significant decline in operating margin to 0.50%, leading to a nearly 20% drop in stock price. This indicates serious operational challenges and underperformance compared to industry peers.

Syschem (India) Ltd's latest results for Q1 FY27 are concerning and can be classified as bad. The company reported a net loss of ₹1.67 crores, which marks a significant decline of 200% year-on-year. Revenue remained relatively flat at ₹109.21 crores, showing only a slight decrease of 0.10% compared to the previous year, but it experienced a dramatic 50.21% drop from the preceding quarter.<BR><BR>The operating margin has also plummeted to just 0.50%, the lowest level in eight quarters, indicating severe operational challenges. This margin compression, coupled with rising costs—particularly a 111.52% increase in employee expenses—has pressured profitability significantly. The market reacted negatively, with the stock price falling by nearly 20% in a single day, hitting a 52-week low.<BR><BR>Overall, the combination of a quarterly loss, collapsing margins, and significant underperformance compared to industry peers suggests that Syschem is facing serious operational difficulties that need urgent attention.

When is the next results date for Syschem (India) Ltd?

The next results date for Syschem (India) Ltd is August 4, 2026.

The next results date for Syschem (India) Ltd is scheduled for August 4, 2026.

Should I buy, sell or hold Syschem (India) Ltd?

How has been the historical performance of Syschem (India)?

Syschem (India) has shown significant sales growth, increasing from 59.00 Cr in Mar'22 to 331.68 Cr in Mar'25, but profitability has declined, with profit after tax dropping from 4.51 Cr in Mar'23 to 0.46 Cr in Mar'25, and cash flow from operations remains negative. Total assets and liabilities grew in tandem, indicating financial challenges despite overall growth.

Answer:<BR>The historical performance of Syschem (India) shows significant fluctuations in key financial metrics over the years, particularly in net sales, operating profit, and profit after tax.<BR><BR>Breakdown:<BR>Syschem (India) has experienced a notable increase in net sales, rising from 59.00 Cr in Mar'22 to 331.68 Cr in Mar'25, reflecting a strong growth trajectory. Total operating income followed a similar trend, reaching 331.68 Cr in Mar'25, up from 59.00 Cr in Mar'22. However, the company's total expenditure also increased significantly, from 58.44 Cr in Mar'22 to 327.69 Cr in Mar'25, primarily driven by rising raw material costs, which surged from 46.97 Cr in Mar'22 to 310.87 Cr in Mar'25. Operating profit (PBDIT) showed volatility, peaking at 8.90 Cr in Mar'23 but dropping to 4.03 Cr in Mar'25. Profit before tax also fluctuated, with a high of 6.15 Cr in Mar'23 and a decline to 1.01 Cr in Mar'25. Profit after tax mirrored this trend, decreasing from 4.51 Cr in Mar'23 to 0.46 Cr in Mar'25. The company's total assets grew from 55.87 Cr in Mar'22 to 216.87 Cr in Mar'25, while total liabilities increased from 55.87 Cr to 216.87 Cr in the same period. Cash flow from operating activities remained negative, indicating ongoing challenges in generating cash from core operations, although cash flow from financing activities showed improvement, contributing to a net cash inflow of 2.00 Cr in Mar'25. Overall, Syschem (India) has shown growth in sales and assets, but profitability and cash flow remain areas of concern.

Is Syschem (India) overvalued or undervalued?

As of August 6, 2025, Syschem (India) is considered very expensive with a PE ratio of 100.12 and low ROCE and ROE, indicating it is overvalued at its current price of 45.79 despite a recent positive stock performance.

As of 6 August 2025, the valuation grade for Syschem (India) has moved from expensive to very expensive. The company is currently overvalued, with a PE ratio of 100.12, an EV to EBITDA of 34.95, and a PEG ratio of 2.03. In comparison, peers such as Solar Industries and Gujarat Fluoroch are also categorized as very expensive, with PE ratios of 112.38 and 64.46, respectively, highlighting that Syschem's valuation is not an outlier in the industry but remains significantly high.<BR><BR>Despite the recent stock performance showing a 3.93% return over the past week compared to a -1.15% return for the Sensex, the overall valuation metrics indicate that Syschem (India) is not justified at its current price of 45.79. The low ROCE of 1.16% and ROE of 2.18% further emphasize the disconnect between its market price and fundamental performance, reinforcing the conclusion that the stock is overvalued.

Who are the top shareholders of the Syschem (India)?

The top shareholders of Syschem (India) include promoter Virendra Popatlal Shah with 10.43%, and Ashika Global Finance Private Limited as the largest public shareholder at 4.44%. Individual investors hold a combined 33.37%, with no pledged promoter holdings or mutual funds/foreign institutional investors involved.

The top shareholders of Syschem (India) include the promoters, with Virendra Popatlal Shah holding the highest individual stake at 10.43%. In terms of public shareholders, Ashika Global Finance Private Limited is the largest, owning 4.44%. Additionally, individual investors collectively hold 33.37% of the company's shares. Notably, there are no pledged promoter holdings, and the company does not have any mutual funds or foreign institutional investors (FIIs) holding shares.

What is the technical trend for Syschem (India)?

As of May 12, 2025, Syschem (India) shows a mildly bearish trend with mixed signals from key indicators, including a mildly bullish weekly MACD and a mildly bearish monthly MACD, suggesting a lack of strong momentum.

As of 12 May 2025, the technical trend for Syschem (India) has changed from bearish to mildly bearish. The weekly MACD is mildly bullish, while the monthly MACD is mildly bearish, indicating mixed signals. The Bollinger Bands show a bullish stance on the weekly chart but are mildly bearish on the monthly chart. Moving averages on the daily timeframe are mildly bearish, suggesting short-term weakness. The KST is mildly bullish on the weekly and mildly bearish on the monthly, further contributing to the mixed outlook. Overall, the current technical stance is mildly bearish, with key indicators reflecting a lack of strong momentum in either direction.

Has Syschem (India) declared dividend?

No Dividend History Available